NYSE

Jackson Acquisition Company II Class A Ordinary Shares (JACS)

647 Thanks from members

Jackson Acquisition Company II (NYSE: JACS) is a healthcare-focused SPAC holding over $230 million in trust, navigating NYSE compliance challenges while trading near its cash floor of approximately $10.73 with mixed valuation and market sentiment.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →